
Exagen XGN
€ 2.36
1.1%
Geschäftsbericht 2025
hinzugefügt 10.03.2026
Exagen EBITDA per Share 2011-2026 | XGN
EBITDA per Share Jährlich Exagen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.56 | -0.66 | -1.17 | -2.6 | -1.45 | -1.16 | -2.43 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.56 | -2.6 | -1.43 |
EBITDA per Share Vierteljährlich Exagen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.11 | -0.1 | -0.16 | - | -0.23 | -0.12 | -0.14 | - | -0.25 | -0.25 | -0.41 | - | -0.43 | -0.81 | -0.55 | - | -0.37 | -0.33 | -0.41 | - | -0.29 | -0.25 | -0.41 | - | -1.36 | -35 | -26.6 | - | -14.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.1 | -35 | -3.79 |
EBITDA per Share anderer Aktien in der Diagnostik & Forschung
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 16.24 | -2.46 % | $ 175 M | ||
|
Co-Diagnostics
CODX
|
-36.9 | $ 1.53 | - | $ 2.04 M | ||
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
5.49 | $ 111.3 | - | $ 33.8 B | ||
|
Fulgent Genetics
FLGT
|
-1.62 | $ 14.8 | - | $ 447 M | ||
|
Illumina
ILMN
|
-3.01 | $ 120.37 | - | $ 19.1 B | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Lantheus Holdings
LNTH
|
5.64 | $ 81.17 | - | $ 5.48 B | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
Medpace Holdings
MEDP
|
19.5 | $ 413.59 | - | $ 11.9 B | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | ||
|
NeoGenomics
NEO
|
-0.62 | $ 8.96 | - | $ 1.15 B | ||
|
National Research Corporation
NRC
|
1.35 | $ 16.54 | - | $ 370 M | ||
|
Koninklijke Philips N.V.
PHG
|
0.61 | $ 25.58 | - | $ 20 B | ||
|
Personalis
PSNL
|
-0.97 | $ 5.04 | - | $ 299 M | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 20.8 | - | $ 1.11 B | ||
|
Senseonics Holdings
SENS
|
-1.6 | $ 6.43 | - | $ 268 M | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M | ||
|
Castle Biosciences
CSTL
|
0.89 | $ 24.24 | - | $ 673 M | ||
|
Thermo Fisher Scientific
TMO
|
23.3 | $ 466.26 | - | $ 176 B | ||
|
Trinity Biotech plc
TRIB
|
0.08 | $ 0.6 | - | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
-1.86 | $ 56.7 | - | $ 3.39 B | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 163.84 | - | $ 8.12 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
-3.17 | $ 83.41 | - | $ 10.5 B | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
1.02 | $ 1.99 | 2.9 % | $ 8.8 M | ||
|
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
-2.2 | $ 2.16 | - | $ 4.96 M | ||
|
ICON Public Limited Company
ICLR
|
19.2 | $ 116.17 | - | $ 9.58 B | ||
|
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 257.14 | - | $ 21.4 B | ||
|
Celcuity
CELC
|
-3.68 | $ 119.0 | - | $ 5.56 B | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-4.34 | $ 9.01 | - | $ 1.95 B | ||
|
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | ||
|
Myriad Genetics
MYGN
|
-3.6 | $ 4.68 | - | $ 433 M | ||
|
OpGen
OPGN
|
0.11 | - | -16.95 % | $ 1.54 M | ||
|
Natera
NTRA
|
-5.33 | $ 194.75 | - | $ 19.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 189.32 | -0.03 % | $ 21 B |